Cargando…
Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication
Autores principales: | Motoyama, Hiroyuki, Tamori, Akihiro, Kubo, Shoji, Uchida-Kobayashi, Sawako, Takemura, Shigekazu, Tanaka, Shogo, Ohfuji, Satoko, Teranishi, Yuga, Kozuka, Ritsuzo, Kawamura, Etsushi, Hagihara, Atsushi, Morikawa, Hiroyasu, Enomoto, Masaru, Murakami, Yoshiki, Kawada, Norifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057673/ https://www.ncbi.nlm.nih.gov/pubmed/30040864 http://dx.doi.org/10.1371/journal.pone.0201423 |
Ejemplares similares
-
Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication
por: Motoyama, Hiroyuki, et al.
Publicado: (2018) -
Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed
por: Yoshida, Kanako, et al.
Publicado: (2017) -
Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma
por: Uchida‐Kobayashi, Sawako, et al.
Publicado: (2022) -
High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use
por: Tamori, Akihiro, et al.
Publicado: (2020) -
Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21
por: Kawamura, Etsushi, et al.
Publicado: (2022)